↓ Skip to main content

Pre-operative chemoradiation followed by post-operative adjuvant therapy with tetrathiomolybdate, a novel copper chelator, for patients with resectable esophageal cancer

Overview of attention for article published in Investigational New Drugs, July 2012
Altmetric Badge

About this Attention Score

  • Among the highest-scoring outputs from this source (#40 of 299)
  • Good Attention Score compared to outputs of the same age (66th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

wikipedia
1 Wikipedia page

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
31 Mendeley
Title
Pre-operative chemoradiation followed by post-operative adjuvant therapy with tetrathiomolybdate, a novel copper chelator, for patients with resectable esophageal cancer
Published in
Investigational New Drugs, July 2012
DOI 10.1007/s10637-012-9864-0
Pubmed ID
Authors

Bryan J. Schneider, Julia Shin-Jung Lee, James A. Hayman, Andrew C. Chang, Mark B. Orringer, Allan Pickens, Charlie C. Pan, Sofia D. Merajver, Susan G. Urba

Mendeley readers

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Croatia 1 3%
United Kingdom 1 3%
Unknown 29 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 19%
Other 6 19%
Student > Master 5 16%
Student > Ph. D. Student 4 13%
Student > Bachelor 3 10%
Other 7 23%
Readers by discipline Count As %
Medicine and Dentistry 20 65%
Nursing and Health Professions 3 10%
Unspecified 2 6%
Biochemistry, Genetics and Molecular Biology 2 6%
Chemistry 2 6%
Other 2 6%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 June 2016.
All research outputs
#1,948,885
of 7,912,542 outputs
Outputs from Investigational New Drugs
#40
of 299 outputs
Outputs of similar age
#83,777
of 263,161 outputs
Outputs of similar age from Investigational New Drugs
#1
of 10 outputs
Altmetric has tracked 7,912,542 research outputs across all sources so far. This one has received more attention than most of these and is in the 61st percentile.
So far Altmetric has tracked 299 research outputs from this source. They receive a mean Attention Score of 3.2. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 263,161 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them